

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.08904280 |
| 2 | DNA strand elongation (GO:0022616) | 4.85163380 |
| 3 | DNA replication initiation (GO:0006270) | 4.81125418 |
| 4 | maturation of SSU-rRNA (GO:0030490) | 4.66024023 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.64119860 |
| 6 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.63698094 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.50549358 |
| 8 | DNA replication checkpoint (GO:0000076) | 4.47558912 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 4.24053984 |
| 10 | viral transcription (GO:0019083) | 4.20102462 |
| 11 | DNA deamination (GO:0045006) | 4.18141259 |
| 12 | telomere maintenance via recombination (GO:0000722) | 4.16504200 |
| 13 | nucleobase biosynthetic process (GO:0046112) | 4.12883860 |
| 14 | translational termination (GO:0006415) | 4.10048202 |
| 15 | protein localization to kinetochore (GO:0034501) | 4.03145867 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 3.96885152 |
| 17 | mitotic recombination (GO:0006312) | 3.95154983 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 3.92348210 |
| 19 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.85004269 |
| 20 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.85004269 |
| 21 | mitotic metaphase plate congression (GO:0007080) | 3.82442786 |
| 22 | translational elongation (GO:0006414) | 3.80205585 |
| 23 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.76707122 |
| 24 | establishment of viral latency (GO:0019043) | 3.73756928 |
| 25 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.72253737 |
| 26 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.70275610 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.70174545 |
| 28 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.67805421 |
| 29 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.65478575 |
| 30 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.65478575 |
| 31 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.65478575 |
| 32 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.64528869 |
| 33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.64528869 |
| 34 | ribosomal large subunit biogenesis (GO:0042273) | 3.63442236 |
| 35 | spliceosomal snRNP assembly (GO:0000387) | 3.62908559 |
| 36 | translational initiation (GO:0006413) | 3.62753534 |
| 37 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61784763 |
| 38 | telomere maintenance via telomere lengthening (GO:0010833) | 3.61425990 |
| 39 | mitotic nuclear envelope disassembly (GO:0007077) | 3.60474036 |
| 40 | ribosome biogenesis (GO:0042254) | 3.59746324 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.57645631 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.53496230 |
| 43 | CENP-A containing nucleosome assembly (GO:0034080) | 3.53074093 |
| 44 | chromatin remodeling at centromere (GO:0031055) | 3.52778417 |
| 45 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.52417605 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.52417605 |
| 47 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.49275344 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.48877974 |
| 49 | IMP biosynthetic process (GO:0006188) | 3.48717775 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.48301324 |
| 51 | protein targeting to ER (GO:0045047) | 3.46461208 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.45435520 |
| 53 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.41822752 |
| 54 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.41739717 |
| 55 | rRNA processing (GO:0006364) | 3.41026255 |
| 56 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.37203201 |
| 57 | protein neddylation (GO:0045116) | 3.37122591 |
| 58 | cellular protein complex disassembly (GO:0043624) | 3.35512275 |
| 59 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.34367120 |
| 60 | mitotic sister chromatid segregation (GO:0000070) | 3.34263133 |
| 61 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.33398405 |
| 62 | DNA replication-independent nucleosome organization (GO:0034724) | 3.33398405 |
| 63 | metaphase plate congression (GO:0051310) | 3.32785792 |
| 64 | nuclear envelope disassembly (GO:0051081) | 3.31327614 |
| 65 | membrane disassembly (GO:0030397) | 3.31327614 |
| 66 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.30206712 |
| 67 | regulation of mitochondrial translation (GO:0070129) | 3.29763528 |
| 68 | rRNA metabolic process (GO:0016072) | 3.29522188 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.29309977 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.29147107 |
| 71 | viral life cycle (GO:0019058) | 3.27294019 |
| 72 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.26191425 |
| 73 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.26012295 |
| 74 | protein localization to endoplasmic reticulum (GO:0070972) | 3.25206108 |
| 75 | DNA ligation (GO:0006266) | 3.24330714 |
| 76 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.22634636 |
| 77 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.22634636 |
| 78 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.22026047 |
| 79 | kinetochore organization (GO:0051383) | 3.19723842 |
| 80 | positive regulation of ligase activity (GO:0051351) | 3.18398559 |
| 81 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.17980585 |
| 82 | spliceosomal complex assembly (GO:0000245) | 3.17907847 |
| 83 | regulation of translation in response to stress (GO:0043555) | 3.17378339 |
| 84 | histone exchange (GO:0043486) | 3.16774063 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.16485033 |
| 86 | establishment of chromosome localization (GO:0051303) | 3.16129816 |
| 87 | protein deneddylation (GO:0000338) | 3.13618459 |
| 88 | protein complex disassembly (GO:0043241) | 3.13598716 |
| 89 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.13234322 |
| 90 | rRNA modification (GO:0000154) | 3.12995597 |
| 91 | cullin deneddylation (GO:0010388) | 3.12607429 |
| 92 | mismatch repair (GO:0006298) | 3.11567300 |
| 93 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.11348001 |
| 94 | establishment of integrated proviral latency (GO:0075713) | 3.11079184 |
| 95 | mitotic chromosome condensation (GO:0007076) | 3.09965896 |
| 96 | histone H2A acetylation (GO:0043968) | 3.09826903 |
| 97 | IMP metabolic process (GO:0046040) | 3.09785039 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.08852717 |
| 99 | negative regulation of ligase activity (GO:0051352) | 3.08852717 |
| 100 | kinetochore assembly (GO:0051382) | 3.06412274 |
| 101 | proteasome assembly (GO:0043248) | 3.04525531 |
| 102 | protein K6-linked ubiquitination (GO:0085020) | 3.03780535 |
| 103 | postreplication repair (GO:0006301) | 3.02593027 |
| 104 | negative regulation of chromosome segregation (GO:0051985) | 3.01994684 |
| 105 | sister chromatid segregation (GO:0000819) | 3.01888676 |
| 106 | macromolecular complex disassembly (GO:0032984) | 3.01852457 |
| 107 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.00474480 |
| 108 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.00474480 |
| 109 | negative regulation of sister chromatid segregation (GO:0033046) | 3.00474480 |
| 110 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.00474480 |
| 111 | viral mRNA export from host cell nucleus (GO:0046784) | 2.99036937 |
| 112 | pseudouridine synthesis (GO:0001522) | 2.98454887 |
| 113 | regulation of chromosome segregation (GO:0051983) | 2.97564759 |
| 114 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.96632548 |
| 115 | mRNA splicing, via spliceosome (GO:0000398) | 2.96632548 |
| 116 | RNA splicing, via transesterification reactions (GO:0000375) | 2.96079217 |
| 117 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.95963836 |
| 118 | translation (GO:0006412) | 2.95513061 |
| 119 | cell cycle G1/S phase transition (GO:0044843) | 2.95216391 |
| 120 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.95216391 |
| 121 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94910856 |
| 122 | nuclear pore organization (GO:0006999) | 2.94827700 |
| 123 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.94786788 |
| 124 | ribosome assembly (GO:0042255) | 2.93518523 |
| 125 | DNA duplex unwinding (GO:0032508) | 2.93125172 |
| 126 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.91899213 |
| 127 | heme metabolic process (GO:0042168) | 2.90229463 |
| 128 | purine nucleotide salvage (GO:0032261) | 2.86091454 |
| 129 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.85256531 |
| 130 | regulation of ligase activity (GO:0051340) | 2.84177643 |
| 131 | chaperone-mediated protein transport (GO:0072321) | 2.81624900 |
| 132 | protein complex biogenesis (GO:0070271) | 2.81338804 |
| 133 | purine-containing compound salvage (GO:0043101) | 2.79723422 |
| 134 | negative regulation of protein ubiquitination (GO:0031397) | 2.78853733 |
| 135 | deoxyribonucleotide catabolic process (GO:0009264) | 2.78446761 |
| 136 | deoxyribose phosphate catabolic process (GO:0046386) | 2.75437372 |
| 137 | protein targeting to mitochondrion (GO:0006626) | 2.75338751 |
| 138 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.72915440 |
| 139 | oxidative phosphorylation (GO:0006119) | 2.72531353 |
| 140 | heme biosynthetic process (GO:0006783) | 2.71502224 |
| 141 | positive regulation of cell cycle arrest (GO:0071158) | 2.71239950 |
| 142 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.71060407 |
| 143 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68413019 |
| 144 | ATP synthesis coupled proton transport (GO:0015986) | 2.68413019 |
| 145 | regulation of cellular amine metabolic process (GO:0033238) | 2.67592284 |
| 146 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.66720688 |
| 147 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.66720688 |
| 148 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.66165608 |
| 149 | signal transduction in response to DNA damage (GO:0042770) | 2.64725144 |
| 150 | pentose metabolic process (GO:0019321) | 2.62402078 |
| 151 | response to interferon-beta (GO:0035456) | 2.61993474 |
| 152 | DNA damage response, detection of DNA damage (GO:0042769) | 2.61977956 |
| 153 | cellular response to interferon-beta (GO:0035458) | 2.59359481 |
| 154 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.58256771 |
| 155 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.58256771 |
| 156 | NADH dehydrogenase complex assembly (GO:0010257) | 2.58256771 |
| 157 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.56479770 |
| 158 | protein localization to mitochondrion (GO:0070585) | 2.51777950 |
| 159 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.49455709 |
| 160 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49345239 |
| 161 | establishment of protein localization to mitochondrion (GO:0072655) | 2.47867586 |
| 162 | DNA topological change (GO:0006265) | 2.47697625 |
| 163 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.45191371 |
| 164 | termination of RNA polymerase III transcription (GO:0006386) | 2.45191371 |
| 165 | respiratory chain complex IV assembly (GO:0008535) | 2.45028559 |
| 166 | cytochrome complex assembly (GO:0017004) | 2.44854071 |
| 167 | replication fork processing (GO:0031297) | 2.44610718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.72076993 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.13244401 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.65428114 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57663056 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.43193438 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.26335062 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.10515488 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.01338622 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.00751987 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97964992 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.94674692 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.94408620 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87430063 |
| 14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.86757400 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.78540203 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.76937712 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.76628474 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49044822 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.47052213 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31006144 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.30243390 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29437636 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10720391 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.07022198 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04185373 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02245963 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01007971 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95591043 |
| 29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.93844840 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.91873906 |
| 31 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.91236164 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90663441 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89771198 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.86660065 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86186374 |
| 36 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.84788879 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84405268 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84322185 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83217536 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78393445 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77773092 |
| 42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76307204 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.69942893 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67008471 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65983444 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63906107 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60304018 |
| 48 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59483112 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58576379 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56534282 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.56120520 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55268421 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54927261 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.54819215 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.53311026 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.52901395 |
| 57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52176753 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48379131 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45887269 |
| 60 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.41283596 |
| 61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41224969 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37230951 |
| 63 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33695610 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.33019201 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27242398 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26892281 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25504351 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23276011 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22609888 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20432686 |
| 71 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18473792 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17841286 |
| 73 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.17220216 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17164207 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16444451 |
| 76 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.14083076 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13580359 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13551290 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11466706 |
| 80 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11162386 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10692347 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10432403 |
| 83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09737122 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08813941 |
| 85 | * E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08300950 |
| 86 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08086614 |
| 87 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07438638 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06037859 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05811352 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04690239 |
| 91 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04430816 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03425796 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00512084 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99271694 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99081912 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98854482 |
| 97 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97309153 |
| 98 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97007903 |
| 99 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93630226 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93493180 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93074445 |
| 102 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92857742 |
| 103 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89250315 |
| 104 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.87992029 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87430135 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86924844 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85843655 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85177362 |
| 109 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.83449737 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 0.81852674 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79103180 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76652946 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.76593719 |
| 114 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76260402 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.75503123 |
| 116 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.73755340 |
| 117 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.71874676 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.71702918 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70792788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.51670927 |
| 2 | MP0010094_abnormal_chromosome_stability | 5.07861820 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.52793642 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.43681577 |
| 5 | MP0003077_abnormal_cell_cycle | 4.09916500 |
| 6 | MP0008058_abnormal_DNA_repair | 3.73140525 |
| 7 | MP0008057_abnormal_DNA_replication | 3.71600031 |
| 8 | MP0008007_abnormal_cellular_replicative | 3.15720779 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.81462836 |
| 10 | MP0008932_abnormal_embryonic_tissue | 2.79114438 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.40881725 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.36525110 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.29607485 |
| 14 | MP0001730_embryonic_growth_arrest | 2.27088757 |
| 15 | MP0000350_abnormal_cell_proliferation | 2.17957351 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.05178888 |
| 17 | MP0001853_heart_inflammation | 2.04956950 |
| 18 | MP0009785_altered_susceptibility_to | 2.04217533 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.00821900 |
| 20 | MP0004147_increased_porphyrin_level | 1.99894904 |
| 21 | MP0003303_peritoneal_inflammation | 1.98221231 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.94931467 |
| 23 | MP0003123_paternal_imprinting | 1.87585476 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.84289873 |
| 25 | MP0006082_CNS_inflammation | 1.82992683 |
| 26 | MP0003786_premature_aging | 1.82602857 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.75435716 |
| 28 | MP0002210_abnormal_sex_determination | 1.74199783 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.70868937 |
| 30 | MP0010307_abnormal_tumor_latency | 1.69966517 |
| 31 | MP0000490_abnormal_crypts_of | 1.69185956 |
| 32 | MP0003718_maternal_effect | 1.69129283 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.67183950 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.66323850 |
| 35 | MP0005451_abnormal_body_composition | 1.64871612 |
| 36 | MP0001697_abnormal_embryo_size | 1.62530134 |
| 37 | MP0001929_abnormal_gametogenesis | 1.62477226 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.61258666 |
| 39 | MP0003436_decreased_susceptibility_to | 1.58325077 |
| 40 | MP0002080_prenatal_lethality | 1.57949386 |
| 41 | MP0005380_embryogenesis_phenotype | 1.57829823 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.57829823 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.55421951 |
| 44 | MP0009764_decreased_sensitivity_to | 1.54399551 |
| 45 | MP0000313_abnormal_cell_death | 1.54305852 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.54089219 |
| 47 | MP0005025_abnormal_response_to | 1.49657933 |
| 48 | MP0002085_abnormal_embryonic_tissue | 1.49028694 |
| 49 | MP0009278_abnormal_bone_marrow | 1.44077526 |
| 50 | MP0006054_spinal_hemorrhage | 1.42962990 |
| 51 | MP0001145_abnormal_male_reproductive | 1.41738273 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.39956746 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.39547180 |
| 54 | MP0009697_abnormal_copulation | 1.38648616 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.38528774 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.38400320 |
| 57 | MP0003984_embryonic_growth_retardation | 1.38341529 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.37342836 |
| 59 | MP0002419_abnormal_innate_immunity | 1.37017167 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.34962217 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 1.34821342 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.34029359 |
| 63 | MP0001764_abnormal_homeostasis | 1.33040433 |
| 64 | MP0002084_abnormal_developmental_patter | 1.31559349 |
| 65 | MP0002398_abnormal_bone_marrow | 1.27925197 |
| 66 | MP0000653_abnormal_sex_gland | 1.27253252 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.27059257 |
| 68 | MP0009379_abnormal_foot_pigmentation | 1.24672857 |
| 69 | MP0000358_abnormal_cell_content/ | 1.17369969 |
| 70 | MP0008469_abnormal_protein_level | 1.16809904 |
| 71 | MP0003121_genomic_imprinting | 1.15630019 |
| 72 | MP0005410_abnormal_fertilization | 1.15457343 |
| 73 | MP0002722_abnormal_immune_system | 1.14312720 |
| 74 | MP0003315_abnormal_perineum_morphology | 1.14265399 |
| 75 | MP0003075_altered_response_to | 1.13910652 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.10664799 |
| 77 | MP0003698_abnormal_male_reproductive | 1.09481163 |
| 78 | MP0004197_abnormal_fetal_growth/weight/ | 1.07481554 |
| 79 | MP0002132_abnormal_respiratory_system | 1.06182909 |
| 80 | MP0009763_increased_sensitivity_to | 1.06135322 |
| 81 | MP0000343_altered_response_to | 1.04904352 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.04248242 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.04220665 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 1.04071663 |
| 85 | MP0005387_immune_system_phenotype | 1.03701294 |
| 86 | MP0001790_abnormal_immune_system | 1.03701294 |
| 87 | MP0002429_abnormal_blood_cell | 1.03357367 |
| 88 | MP0000516_abnormal_urinary_system | 1.03206758 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 1.03206758 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 1.02363068 |
| 91 | MP0009840_abnormal_foam_cell | 0.99385429 |
| 92 | MP0003724_increased_susceptibility_to | 0.99173730 |
| 93 | MP0001119_abnormal_female_reproductive | 0.98257200 |
| 94 | MP0001293_anophthalmia | 0.97935024 |
| 95 | MP0002160_abnormal_reproductive_system | 0.96606310 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95351357 |
| 97 | MP0008995_early_reproductive_senescence | 0.94158040 |
| 98 | MP0005671_abnormal_response_to | 0.93153820 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.90610036 |
| 100 | MP0000049_abnormal_middle_ear | 0.90379557 |
| 101 | MP0000716_abnormal_immune_system | 0.89837346 |
| 102 | MP0004133_heterotaxia | 0.89413517 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.89326355 |
| 104 | MP0008260_abnormal_autophagy | 0.89033757 |
| 105 | MP0003195_calcinosis | 0.88477276 |
| 106 | MP0000858_altered_metastatic_potential | 0.88347591 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 0.88297622 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.88297622 |
| 109 | MP0001835_abnormal_antigen_presentation | 0.87773998 |
| 110 | MP0005165_increased_susceptibility_to | 0.85945158 |
| 111 | MP0003119_abnormal_digestive_system | 0.85373374 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.84860540 |
| 113 | MP0005389_reproductive_system_phenotype | 0.84536666 |
| 114 | MP0003011_delayed_dark_adaptation | 0.83158390 |
| 115 | MP0002161_abnormal_fertility/fecundity | 0.82839553 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.82422009 |
| 117 | MP0003448_altered_tumor_morphology | 0.80450153 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.77602843 |
| 119 | MP0005384_cellular_phenotype | 0.76447466 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.75679408 |
| 121 | MP0000685_abnormal_immune_system | 0.75629822 |
| 122 | MP0008873_increased_physiological_sensi | 0.75590430 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.75077729 |
| 124 | MP0005395_other_phenotype | 0.74743755 |
| 125 | MP0001819_abnormal_immune_cell | 0.74390766 |
| 126 | MP0002405_respiratory_system_inflammati | 0.73966414 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.73578487 |
| 128 | MP0002095_abnormal_skin_pigmentation | 0.72296394 |
| 129 | MP0001800_abnormal_humoral_immune | 0.72197246 |
| 130 | MP0005075_abnormal_melanosome_morpholog | 0.69233719 |
| 131 | MP0009672_abnormal_birth_weight | 0.69209829 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.68165009 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66272954 |
| 134 | MP0002102_abnormal_ear_morphology | 0.65946854 |
| 135 | MP0002452_abnormal_antigen_presenting | 0.65825854 |
| 136 | MP0000428_abnormal_craniofacial_morphol | 0.65016113 |
| 137 | MP0005076_abnormal_cell_differentiation | 0.65001150 |
| 138 | MP0003943_abnormal_hepatobiliary_system | 0.64696847 |
| 139 | MP0003186_abnormal_redox_activity | 0.64423857 |
| 140 | MP0002111_abnormal_tail_morphology | 0.64221387 |
| 141 | MP0000537_abnormal_urethra_morphology | 0.63529732 |
| 142 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63286148 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.63243566 |
| 144 | MP0005621_abnormal_cell_physiology | 0.60544988 |
| 145 | MP0003937_abnormal_limbs/digits/tail_de | 0.60525468 |
| 146 | MP0001919_abnormal_reproductive_system | 0.60170171 |
| 147 | MP0002092_abnormal_eye_morphology | 0.59452676 |
| 148 | MP0005499_abnormal_olfactory_system | 0.59222009 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.59222009 |
| 150 | MP0002723_abnormal_immune_serum | 0.58515757 |
| 151 | MP0001915_intracranial_hemorrhage | 0.58498419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.41829347 |
| 2 | Reticulocytopenia (HP:0001896) | 5.03565468 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.08305210 |
| 4 | Breast hypoplasia (HP:0003187) | 4.01561289 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.94335588 |
| 6 | Acute encephalopathy (HP:0006846) | 3.80576413 |
| 7 | Abnormality of the anterior horn cell (HP:0006802) | 3.70442137 |
| 8 | Degeneration of anterior horn cells (HP:0002398) | 3.70442137 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.70360242 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.69011531 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65413209 |
| 12 | Patellar aplasia (HP:0006443) | 3.49778804 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.48478276 |
| 14 | Increased CSF lactate (HP:0002490) | 3.45089079 |
| 15 | Colon cancer (HP:0003003) | 3.43338986 |
| 16 | Agnosia (HP:0010524) | 3.41641415 |
| 17 | Petechiae (HP:0000967) | 3.39897686 |
| 18 | Chromsome breakage (HP:0040012) | 3.36824543 |
| 19 | Microvesicular hepatic steatosis (HP:0001414) | 3.31707505 |
| 20 | Hepatic necrosis (HP:0002605) | 3.31270306 |
| 21 | Selective tooth agenesis (HP:0001592) | 3.30814893 |
| 22 | Ependymoma (HP:0002888) | 3.30444573 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.28107892 |
| 24 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.26686131 |
| 25 | Carpal bone hypoplasia (HP:0001498) | 3.24746981 |
| 26 | Medulloblastoma (HP:0002885) | 3.17272187 |
| 27 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.13184847 |
| 28 | Progressive macrocephaly (HP:0004481) | 3.13072935 |
| 29 | Impulsivity (HP:0100710) | 3.11545772 |
| 30 | Macrocytic anemia (HP:0001972) | 3.05230544 |
| 31 | Pallor (HP:0000980) | 3.00829278 |
| 32 | Cerebral edema (HP:0002181) | 2.98586782 |
| 33 | Oral leukoplakia (HP:0002745) | 2.95220673 |
| 34 | Cerebral hypomyelination (HP:0006808) | 2.93658509 |
| 35 | Increased serum pyruvate (HP:0003542) | 2.92148289 |
| 36 | 11 pairs of ribs (HP:0000878) | 2.90277206 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 2.88359832 |
| 38 | Rhabdomyosarcoma (HP:0002859) | 2.81695117 |
| 39 | Nausea (HP:0002018) | 2.81260042 |
| 40 | Meckel diverticulum (HP:0002245) | 2.80451873 |
| 41 | Abnormal protein glycosylation (HP:0012346) | 2.78256465 |
| 42 | Abnormal glycosylation (HP:0012345) | 2.78256465 |
| 43 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.78256465 |
| 44 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.78256465 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.76142454 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.76027810 |
| 47 | Abnormality of the ileum (HP:0001549) | 2.74317307 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.73890054 |
| 49 | Abnormality of the preputium (HP:0100587) | 2.73382513 |
| 50 | Absent thumb (HP:0009777) | 2.71392175 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.71297129 |
| 52 | Abnormality of chromosome stability (HP:0003220) | 2.71013385 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.70898044 |
| 54 | Lactic acidosis (HP:0003128) | 2.67896134 |
| 55 | Increased serum ferritin (HP:0003281) | 2.63066578 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.60123954 |
| 57 | Cholecystitis (HP:0001082) | 2.60123954 |
| 58 | Thrombocytosis (HP:0001894) | 2.58769513 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.56269310 |
| 60 | Aplastic anemia (HP:0001915) | 2.55117610 |
| 61 | Rough bone trabeculation (HP:0100670) | 2.54838864 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.52845226 |
| 63 | Stomatitis (HP:0010280) | 2.50532624 |
| 64 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.49389237 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48705878 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48705878 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48705878 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.46212406 |
| 69 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.45203685 |
| 70 | Premature graying of hair (HP:0002216) | 2.43687293 |
| 71 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.43471845 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.42695694 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.41741544 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.40578185 |
| 75 | Exercise intolerance (HP:0003546) | 2.40193640 |
| 76 | Reduced antithrombin III activity (HP:0001976) | 2.39965490 |
| 77 | Premature ovarian failure (HP:0008209) | 2.38988875 |
| 78 | Abnormal number of incisors (HP:0011064) | 2.36064346 |
| 79 | Neoplasm of the pancreas (HP:0002894) | 2.35787920 |
| 80 | Respiratory failure (HP:0002878) | 2.35687958 |
| 81 | Bone marrow hypocellularity (HP:0005528) | 2.32338943 |
| 82 | Increased IgM level (HP:0003496) | 2.31585111 |
| 83 | Secondary amenorrhea (HP:0000869) | 2.28767642 |
| 84 | Horseshoe kidney (HP:0000085) | 2.28677849 |
| 85 | Emotional lability (HP:0000712) | 2.28641734 |
| 86 | Small intestinal stenosis (HP:0012848) | 2.28572708 |
| 87 | Duodenal stenosis (HP:0100867) | 2.28572708 |
| 88 | Absent epiphyses (HP:0010577) | 2.27327231 |
| 89 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.27327231 |
| 90 | Exertional dyspnea (HP:0002875) | 2.23488903 |
| 91 | Basal cell carcinoma (HP:0002671) | 2.22930963 |
| 92 | Limb hypertonia (HP:0002509) | 2.21401101 |
| 93 | Lethargy (HP:0001254) | 2.21148580 |
| 94 | Myelodysplasia (HP:0002863) | 2.20127364 |
| 95 | Abnormality of B cell number (HP:0010975) | 2.18897546 |
| 96 | Absent radius (HP:0003974) | 2.18848414 |
| 97 | Trismus (HP:0000211) | 2.18607977 |
| 98 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.18572917 |
| 99 | Sloping forehead (HP:0000340) | 2.16111141 |
| 100 | Neoplasm of striated muscle (HP:0009728) | 2.15983440 |
| 101 | B lymphocytopenia (HP:0010976) | 2.15569050 |
| 102 | Abnormal lung lobation (HP:0002101) | 2.15252614 |
| 103 | Microretrognathia (HP:0000308) | 2.13883089 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12876221 |
| 105 | Recurrent viral infections (HP:0004429) | 2.09365782 |
| 106 | Purpura (HP:0000979) | 2.08692138 |
| 107 | Abnormality of the astrocytes (HP:0100707) | 2.08286467 |
| 108 | Astrocytoma (HP:0009592) | 2.08286467 |
| 109 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07371720 |
| 110 | Cellular immunodeficiency (HP:0005374) | 2.07305450 |
| 111 | Amaurosis fugax (HP:0100576) | 2.07023240 |
| 112 | Tracheoesophageal fistula (HP:0002575) | 2.06582687 |
| 113 | Optic nerve coloboma (HP:0000588) | 2.06078970 |
| 114 | Type I transferrin isoform profile (HP:0003642) | 2.05262395 |
| 115 | Lymphoma (HP:0002665) | 2.03534720 |
| 116 | Respiratory difficulties (HP:0002880) | 2.02899994 |
| 117 | Absent forearm bone (HP:0003953) | 2.00900550 |
| 118 | Aplasia involving forearm bones (HP:0009822) | 2.00900550 |
| 119 | Poikiloderma (HP:0001029) | 2.00443200 |
| 120 | Triphalangeal thumb (HP:0001199) | 1.99813189 |
| 121 | CNS demyelination (HP:0007305) | 1.99588382 |
| 122 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96473449 |
| 123 | Dicarboxylic aciduria (HP:0003215) | 1.96473449 |
| 124 | Abnormality of the labia minora (HP:0012880) | 1.96338295 |
| 125 | Slender long bone (HP:0003100) | 1.95997630 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 1.93405895 |
| 127 | Abdominal situs inversus (HP:0003363) | 1.91935832 |
| 128 | Abnormality of abdominal situs (HP:0011620) | 1.91935832 |
| 129 | Pancytopenia (HP:0001876) | 1.91928202 |
| 130 | Ectopic kidney (HP:0000086) | 1.91654171 |
| 131 | Atresia of the external auditory canal (HP:0000413) | 1.91633536 |
| 132 | Glioma (HP:0009733) | 1.91503890 |
| 133 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91438038 |
| 134 | IgM deficiency (HP:0002850) | 1.90806303 |
| 135 | Increased nuchal translucency (HP:0010880) | 1.89884483 |
| 136 | Loss of speech (HP:0002371) | 1.89802673 |
| 137 | Abnormality of DNA repair (HP:0003254) | 1.89257218 |
| 138 | Abnormality of the carotid arteries (HP:0005344) | 1.89237442 |
| 139 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89221460 |
| 140 | Cleft eyelid (HP:0000625) | 1.88362440 |
| 141 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86200328 |
| 142 | Opisthotonus (HP:0002179) | 1.86144156 |
| 143 | Pulmonary fibrosis (HP:0002206) | 1.84911331 |
| 144 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.84361493 |
| 145 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.84361493 |
| 146 | Hypoplasia of the radius (HP:0002984) | 1.83681751 |
| 147 | Abnormality of the prostate (HP:0008775) | 1.83430997 |
| 148 | Personality changes (HP:0000751) | 1.82477594 |
| 149 | Posterior subcapsular cataract (HP:0007787) | 1.82015026 |
| 150 | Abnormality of reticulocytes (HP:0004312) | 1.81754803 |
| 151 | CNS hypomyelination (HP:0003429) | 1.81283928 |
| 152 | Neutropenia (HP:0001875) | 1.81148869 |
| 153 | Prolonged bleeding time (HP:0003010) | 1.80983523 |
| 154 | Abnormality of macrophages (HP:0004311) | 1.80282950 |
| 155 | Supernumerary spleens (HP:0009799) | 1.79159971 |
| 156 | Abnormality of the duodenum (HP:0002246) | 1.79125369 |
| 157 | Autoimmune hemolytic anemia (HP:0001890) | 1.78784608 |
| 158 | Hyperglycinemia (HP:0002154) | 1.78340733 |
| 159 | Multiple enchondromatosis (HP:0005701) | 1.76472806 |
| 160 | Neoplasm of the colon (HP:0100273) | 1.76458212 |
| 161 | Progressive microcephaly (HP:0000253) | 1.76201635 |
| 162 | Combined immunodeficiency (HP:0005387) | 1.75784503 |
| 163 | Duplicated collecting system (HP:0000081) | 1.73859314 |
| 164 | Proximal placement of thumb (HP:0009623) | 1.73576039 |
| 165 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.73307124 |
| 166 | Pendular nystagmus (HP:0012043) | 1.71344716 |
| 167 | Increased serum lactate (HP:0002151) | 1.71220965 |
| 168 | Glossoptosis (HP:0000162) | 1.70836770 |
| 169 | Muscle fiber atrophy (HP:0100295) | 1.70471386 |
| 170 | Abnormal trabecular bone morphology (HP:0100671) | 1.70260491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.94346216 |
| 2 | BUB1 | 4.93268926 |
| 3 | CDC7 | 4.08646747 |
| 4 | WEE1 | 3.86741781 |
| 5 | TLK1 | 3.08200431 |
| 6 | SRPK1 | 2.85160986 |
| 7 | EIF2AK1 | 2.73489570 |
| 8 | TESK2 | 2.67570524 |
| 9 | BCKDK | 2.58943336 |
| 10 | NEK2 | 2.47984380 |
| 11 | TSSK6 | 2.46764011 |
| 12 | MAP4K2 | 2.32686184 |
| 13 | PASK | 2.28227148 |
| 14 | TTK | 2.17642793 |
| 15 | VRK1 | 2.14912798 |
| 16 | STK16 | 2.05378529 |
| 17 | PLK1 | 2.00643155 |
| 18 | DYRK3 | 2.00609387 |
| 19 | EIF2AK3 | 1.96072623 |
| 20 | NUAK1 | 1.91092747 |
| 21 | ACVR1B | 1.87970996 |
| 22 | ATR | 1.78931281 |
| 23 | FLT3 | 1.77303774 |
| 24 | NME2 | 1.68999496 |
| 25 | PLK4 | 1.68795992 |
| 26 | BRSK2 | 1.62581977 |
| 27 | MAP3K10 | 1.62394839 |
| 28 | CDK7 | 1.61511510 |
| 29 | RPS6KB2 | 1.59188131 |
| 30 | AURKB | 1.56292753 |
| 31 | TRIM28 | 1.53937645 |
| 32 | IRAK3 | 1.48600827 |
| 33 | AURKA | 1.48319906 |
| 34 | NEK1 | 1.47685282 |
| 35 | CHEK2 | 1.47475134 |
| 36 | EEF2K | 1.46449810 |
| 37 | CCNB1 | 1.43612420 |
| 38 | TAF1 | 1.43603897 |
| 39 | PLK3 | 1.42985386 |
| 40 | TGFBR1 | 1.41328770 |
| 41 | MKNK1 | 1.39610702 |
| 42 | MATK | 1.39219549 |
| 43 | BRSK1 | 1.29248313 |
| 44 | MAP3K12 | 1.24439801 |
| 45 | MAP4K1 | 1.21448449 |
| 46 | CDK8 | 1.20239070 |
| 47 | TESK1 | 1.19359257 |
| 48 | STK10 | 1.19034281 |
| 49 | TAOK2 | 1.17276221 |
| 50 | MAP3K8 | 1.17257815 |
| 51 | ABL2 | 1.17027146 |
| 52 | RPS6KA4 | 1.15877017 |
| 53 | SCYL2 | 1.15597594 |
| 54 | CHEK1 | 1.14254476 |
| 55 | GRK7 | 1.10408520 |
| 56 | PDK3 | 1.09276250 |
| 57 | PDK4 | 1.09276250 |
| 58 | CDK4 | 1.02320895 |
| 59 | MAP3K11 | 1.01869399 |
| 60 | IKBKB | 1.00913448 |
| 61 | CLK1 | 0.97145167 |
| 62 | KIT | 0.95345435 |
| 63 | DYRK2 | 0.95260167 |
| 64 | PIM2 | 0.92519129 |
| 65 | BRAF | 0.90074808 |
| 66 | MKNK2 | 0.87641103 |
| 67 | TBK1 | 0.85080850 |
| 68 | PAK4 | 0.83401230 |
| 69 | PIM1 | 0.83173804 |
| 70 | KDR | 0.82520029 |
| 71 | ATM | 0.80569437 |
| 72 | MAPKAPK3 | 0.80111032 |
| 73 | CDK2 | 0.79284803 |
| 74 | LRRK2 | 0.78984441 |
| 75 | TIE1 | 0.78811386 |
| 76 | FGR | 0.76865670 |
| 77 | CSF1R | 0.73861614 |
| 78 | CDK12 | 0.72917953 |
| 79 | CSNK2A2 | 0.72456070 |
| 80 | CSNK2A1 | 0.69019709 |
| 81 | STK4 | 0.67433901 |
| 82 | INSRR | 0.67339734 |
| 83 | BTK | 0.63498706 |
| 84 | CDK1 | 0.61389176 |
| 85 | NME1 | 0.60900743 |
| 86 | CSNK1G3 | 0.60574072 |
| 87 | PAK1 | 0.60412293 |
| 88 | SIK3 | 0.58990391 |
| 89 | MAP3K5 | 0.58894952 |
| 90 | PRPF4B | 0.57431284 |
| 91 | MAPKAPK5 | 0.54853547 |
| 92 | CDK9 | 0.53672801 |
| 93 | RPS6KA5 | 0.51505242 |
| 94 | ZAP70 | 0.51362311 |
| 95 | YES1 | 0.50164694 |
| 96 | ZAK | 0.49184168 |
| 97 | IKBKE | 0.48807753 |
| 98 | BMPR2 | 0.47517963 |
| 99 | MELK | 0.47053175 |
| 100 | LIMK1 | 0.44507190 |
| 101 | PIK3CG | 0.42214674 |
| 102 | TEC | 0.40656446 |
| 103 | IRAK4 | 0.40061091 |
| 104 | ILK | 0.38868270 |
| 105 | DAPK3 | 0.38713847 |
| 106 | EIF2AK2 | 0.38536412 |
| 107 | FES | 0.38265209 |
| 108 | BLK | 0.37644525 |
| 109 | SYK | 0.36895383 |
| 110 | JAK3 | 0.36565774 |
| 111 | PBK | 0.36389600 |
| 112 | CSNK1A1L | 0.35813297 |
| 113 | DAPK1 | 0.35477705 |
| 114 | ITK | 0.35028214 |
| 115 | PRKCI | 0.34600067 |
| 116 | CSNK1G2 | 0.33676206 |
| 117 | TXK | 0.32665030 |
| 118 | MAP3K3 | 0.32352667 |
| 119 | ALK | 0.30923782 |
| 120 | MAP3K14 | 0.30529833 |
| 121 | RAF1 | 0.30471011 |
| 122 | ADRBK2 | 0.30199411 |
| 123 | WNK3 | 0.29884006 |
| 124 | TYK2 | 0.29231296 |
| 125 | BRD4 | 0.29144409 |
| 126 | CSNK1G1 | 0.29086832 |
| 127 | PDK2 | 0.26042348 |
| 128 | LYN | 0.24769776 |
| 129 | GRK6 | 0.24204894 |
| 130 | RPS6KA1 | 0.24174481 |
| 131 | PRKDC | 0.22947368 |
| 132 | MET | 0.22144674 |
| 133 | EPHA2 | 0.21528987 |
| 134 | NEK9 | 0.21276303 |
| 135 | LCK | 0.20138796 |
| 136 | CSNK1E | 0.19296814 |
| 137 | MAPK9 | 0.19264400 |
| 138 | MST4 | 0.18168219 |
| 139 | RPS6KC1 | 0.17666013 |
| 140 | RPS6KL1 | 0.17666013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.22149533 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.36758293 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.80175317 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.44322143 |
| 5 | * Spliceosome_Homo sapiens_hsa03040 | 3.39585448 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.36025277 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.28108265 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 3.18611566 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 3.13505078 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.94639713 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.87217951 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 2.67803436 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.59300699 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.51008583 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.39371833 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.19662525 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.14456060 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 2.02598154 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.87291660 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81004298 |
| 21 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.62807769 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56108529 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44624451 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.38380022 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38003253 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28690379 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.28603355 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.27429880 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24307463 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23700725 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15906066 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12162991 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.09460109 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05981353 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00953612 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98151857 |
| 37 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96528089 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95072451 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94317173 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93417671 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90853850 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89644327 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.89524809 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89229362 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.88644603 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87363120 |
| 47 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87007566 |
| 48 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84865848 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79849927 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78244307 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77167239 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75892174 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75703251 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75174447 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74284604 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71287640 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70890456 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69499365 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68639202 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66893767 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66341919 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66029135 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.63140653 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62778110 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61845808 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.61350380 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60640921 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60629239 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60509312 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57964776 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56071840 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54624914 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54342813 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52551282 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52324717 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.51779442 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51616589 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50344602 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49652656 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.49430451 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49217376 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47702340 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.47025160 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46718939 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46476273 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45423932 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45305430 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44650138 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44178982 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43624605 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42842354 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42610663 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.42574437 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.41668070 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.41331255 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39623899 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39404329 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38510859 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38058871 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32628210 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.32595017 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32378593 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31647746 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.30426238 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30178937 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28579247 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27172008 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27106050 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25897004 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25236530 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24349661 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22842173 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21674086 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21385811 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21185525 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21075351 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.20108301 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19975843 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18768354 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18146005 |
| 121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.17807737 |
| 122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17080468 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.16079738 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.16034091 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14606043 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.12901403 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12789399 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12173148 |
| 129 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11351105 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.11240782 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.11205501 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08741934 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07744323 |
| 134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.06881885 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.06778405 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.06348199 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.05353053 |

